KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis (Q40161488)

18 September 2017

KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis (English)

1 reference

18 September 2017

0 references

Sirach E

1

1 reference

18 September 2017

Bureau C

2

1 reference

18 September 2017

Péron JM

3

1 reference

18 September 2017

Pradayrol L

4

1 reference

18 September 2017

Vinel JP

5

1 reference

18 September 2017

Buscail L

6

1 reference

18 September 2017

Cordelier P

7

1 reference

18 September 2017

9 March 2007

1 reference

Cell Death & Differentiation

18 September 2017

1 reference

18 September 2017

14

1 reference

18 September 2017

1202-1210

1 reference

18 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4402114

18 September 2017

0 references

cites work

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

KLF6, a candidate tumor suppressor gene mutated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

KLF6 is one transcription factor involved in regulating acid ceramidase gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Expression and role of Bcl-xL in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Intrinsic tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Genetic alterations of the KLF6 gene in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

KLF6 is not the major target of chromosome 10p losses in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Absence of KLF6 gene mutations in human astrocytic tumors and cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Molecular interaction map of the mammalian cell cycle control and DNA repair systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

A new role for the Krüppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

Rising incidence of hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

7 January 2021

High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

7 January 2021

Absence of KLF6 gene mutation in 71 hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

7 January 2021

KLF6mRNA expression in primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

7 January 2021

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

7 January 2021

Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402114

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4402114

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference